Do you want to read an article? Please log in or register.
High Prevalence of CYP2C19 Rapid and Ultrarapid Metabolism among Patients with Gastroesophageal Reflux Disease
Gastroesophageal Reflux Disease (GERD)
Related content
Further Publications
Effect of high dose N-acetyl cysteine supplementation on markers of oxidative stress and insulin resistance in non-diabetic patients with metabolic dysfunction associated steatotic liver disease: a randomized controlled trial
BMC Gastroenterol
Ramadan AM, El-Wakeel LM, Adel A, Abdel-Wahab M, Fahmy SF
doi: 10.1186/s12876-026-05157-x
Gastroesophageal Reflux Disease (GERD)
Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Non-Erosive Reflux Disease
Am J Gastroenterol
Antunes C, Ghosh G, Katz P, Yadlapati R, Leifke E, Harris T, Graham H, Laine L
doi: 10.14309/ajg.0000000000003794
Further Publications
Clinical Care Pathway for the Risk Stratification and Management of Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
Gastroenterology
Kanwal F, Bril F, Wai-Sun Wong V, Adams LA, Pfotenhauer K, Skolnik N, Wright EE Jr, Eckel RH, Noureddin M, Loomba R, Allen AM, Bansal MB, Godwin KM, El-Serag HB, Shubrook JH
doi: 10.1053/j.gastro.2026.01.047
HepatitisHepatology
Steatosis grade and cardiometabolic burden as determinants of hepatocellular carcinoma risk after hepatitis C cure in patients with metabolic dysfunction-associated steatotic liver disease
Gut
Chang YP, Chen YC, Cheng PN, Fang YJ, Chen CY, Kao WY, Lin CL, Yang SS, Shih YL, Peng CY, Lee FJ, Tsai MC, Huang SC, Su TH, Tseng TC, Liu CJ, Chen PJ, Kao JH, Liu CH
doi: 10.1136/gutjnl-2025-337275
Hepatology
Risk of hepatic and extrahepatic outcomes associated with metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated steatotic liver disease: a systematic review and meta-analysis
Lancet Gastroenterol Hepatol
Celsa C, Pennisi G, Tulone A, Ciancimino G, Vaccaro M, Pecorella F, Di Maria G, Enea M, Midiri F, Mantovani A, Targher G, Krag A, Rinella ME, Cammà C, Petta S
doi: 10.1016/S2468-1253(25)00188-8
Hepatology
Vitamin E dosing study (VEDS) in patients with metabolic dysfunction-associated steatotic liver disease with elevated aminotransferases: A multicenter, randomized, placebo-controlled trial
Hepatology
Dasarathy S, Mitchell EP, Wilson LA, Neuschwander-Tetri BA, Chalasani N, Clark JM, Diehl AM, Hameed B, Loomba R, Yuan L, Kowdley KV, Sanyal AJ, NASH Clinical Research Network
doi: 10.1097/HEP.0000000000001797
COMMENTED
Celiac Disease
Disease course and symptoms in smoking versus non-smoking patients with Celiac disease
★ 3
Recommended and commented by
Prof. Dr Stephan Vavricka, Faculty Member
Acta Gastroenterol Belg
Balsiger L, Himmelmann A, Vavricka SR, Schreiner P, Greuter T, Scharl M, Schoepfer AM, Rogler G, Green PHR, Zeitz J, Biederman L
doi: 10.51821/88.4.14272
Hepatology
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study
Lancet Gastroenterol Hepatol
Lazarus JV, Agirre-Garrido L, White TM, Arora AK, Manolas MI, Diaz LA, Arab JP, Zelber-Sagi S, Alkhouri N, Spearman CW, Schattenberg JM, Kondili LA, Carrieri P, Lofton HF, Jaisinghani P, Kumar S, Duseja A, El-Kassas M, Takahasi H, Shawcross DL, Stine JG, Villota-Rivas M, Miralles-Sanchez JE, Pannain S, Brennan PN, MASLD/MASH Collaborators
doi: 10.1016/S2468-1253(25)00300-0
Hepatology
Comparative efficacy of different diet modalities on metabolic profiles and liver functions in metabolic dysfunction-associated fatty liver disease: a network meta-analysis
BMC Gastroenterol
Zou J, Tian F, Cui S, Hou J, Li Z, Wei Y, Cui H, Li Y, Zhou S, He Z, Ma X
doi: 10.1186/s12876-025-04535-1